These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 9524097)

  • 1. Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy.
    Dziuk TW; Woo S; Butler EB; Thornby J; Grossman R; Dennis WS; Lu H; Carpenter LS; Chiu JK
    J Neurooncol; 1998 Apr; 37(2):177-88. PubMed ID: 9524097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
    Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
    Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiotherapy for atypical meningiomas.
    Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
    J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.
    Hug EB; Devries A; Thornton AF; Munzenride JE; Pardo FS; Hedley-Whyte ET; Bussiere MR; Ojemann R
    J Neurooncol; 2000 Jun; 48(2):151-60. PubMed ID: 11083080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early adjuvant radiotherapy in the treatment of atypical meningioma.
    Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
    J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial meningeal hemangiopericytoma: 10 years experience of a tertiary care Institute.
    Kumar N; Kumar R; Kapoor R; Ghoshal S; Kumar P; Salunke PS; Radotra BD; Sharma SC
    Acta Neurochir (Wien); 2012 Sep; 154(9):1647-51. PubMed ID: 22790838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients.
    Glaholm J; Bloom HJ; Crow JH
    Int J Radiat Oncol Biol Phys; 1990 Apr; 18(4):755-61. PubMed ID: 2108937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma.
    Ware ML; Larson DA; Sneed PK; Wara WW; McDermott MW
    Neurosurgery; 2004 Jan; 54(1):55-63; discussion 63-4. PubMed ID: 14683541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skull base atypical meningioma: long term surgical outcome and prognostic factors.
    Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY
    Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
    Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
    Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of radiotherapy following gross-total resection of atypical meningiomas.
    Komotar RJ; Iorgulescu JB; Raper DM; Holland EC; Beal K; Bilsky MH; Brennan CW; Tabar V; Sherman JH; Yamada Y; Gutin PH
    J Neurosurg; 2012 Oct; 117(4):679-86. PubMed ID: 22920955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Resection and Interstitial Iodine-125 Brachytherapy for High-Grade Meningiomas: A 25-Year Series.
    Magill ST; Lau D; Raleigh DR; Sneed PK; Fogh SE; McDermott MW
    Neurosurgery; 2017 Mar; 80(3):409-416. PubMed ID: 27258768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early postoperative radiotherapy improves progression free survival in patients with grade 2 meningioma.
    Aboukais R; Baroncini M; Zairi F; Reyns N; Lejeune JP
    Acta Neurochir (Wien); 2013 Aug; 155(8):1385-90; discussion 1390. PubMed ID: 23728501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local control and overall survival in atypical meningioma: a retrospective study.
    Goyal LK; Suh JH; Mohan DS; Prayson RA; Lee J; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):57-61. PubMed ID: 10656373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy.
    Masalha W; Heiland DH; Franco P; Delev D; Haaker JG; Schnell O; Scheiwe C; Grauvogel J
    J Neurooncol; 2018 Jan; 136(1):147-154. PubMed ID: 29081038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of radiosurgery during management of aggressive meningiomas.
    Harris AE; Lee JY; Omalu B; Flickinger JC; Kondziolka D; Lunsford LD
    Surg Neurol; 2003 Oct; 60(4):298-305; discussion 305. PubMed ID: 14505844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
    Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
    Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
    Hammouche S; Clark S; Wong AH; Eldridge P; Farah JO
    Acta Neurochir (Wien); 2014 Aug; 156(8):1475-81. PubMed ID: 24965072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
    Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
    J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.